3-Dimensional Pharmaceuticals Inc., of Yardley, Pa., promoted John Gill to chief operating officer and appointed Melinda Rudolph vice president and general counsel.
Absorption Systems, of Exton, Pa., appointed Albert Owen vice president, strategic planning.
Active Pass Pharmaceuticals Inc., of Vancouver, British Columbia, appointed Rod Campbell as vice president and chief financial officer.
ActivX Biosciences Inc., of La Jolla, Calif., added Michael Dunn as executive vice president, business development.
Ardana Bioscience, of Edinburgh, UK, appointed Finn Larsen director of clinical development.
Avigen Inc., of San Francisco, appointed Daniel Vapnek to its board.
Biotechnology Industry Organization, of Washington, named Dennis Fenton and Susan Desmond-Hellmann to its board.
Cepheid Inc., of Sunnyvale, Calif., appointed Tony Godfrey to its scientific advisory board.
Corgentech Inc., of Palo Alto, Calif., promoted Leslie McEvoy to vice president of research.
DeveloGen AG, of Goettingen, Germany, added Jesper Wiklund as vice president of business development and promoted Cord Dohrmann to vice president of research.
DiaDexus Inc., of South San Francisco, appointed Jacqueline Papkoff vice president, discovery.
DNAPrint genomics Inc., of Sarasota, Fla., named Jack Luchese and Hector Gomez to its board.
Enzon Inc., of Piscataway, N.J., appointed Robert Parkinson to its board.
ExonHit Therapeutics SA, of Paris, added Philippe Guillet as vice president of clinical research.
Genaera Corp., of Plymouth Meeting, Pa., appointed David Jarosz executive vice president and chief business officer and promoted Kenneth Holroyd to executive vice president and chief operating officer.
Genentech Inc., of South San Francisco, promoted Gene Murano to vice president, regulatory affairs.
Genoptix Inc., of San Diego, appointed Thomas Chung chief scientific officer and Samuel Riccitelli senior vice president, operations.
Guilford Pharmaceuticals Inc., of Baltimore, appointed David Wright president and chief business officer.
Inhibitex Inc., of Atlanta, appointed James Barrett and Douglas Eplett to its board.
Ionix Pharmaceuticals Ltd., of Cambridge, UK, appointment Kelly Chessum financial controller.
Isis Pharmaceuticals Inc., of Carlsbad, Calif., elected John Reed to its board.
MaxCyte Inc., of Rockville, Md., named Michael Blaese to its scientific advisory board.
NeoGenomics Inc., of Naples, Fla., named Navnit Mitter director of its cytogenetics, molecular biology and genetic research laboratory.
Neose Technologies Inc., of Horsham, Pa., promoted David Zopf to executive vice president and appointed Jerry Middleton to director, commercial development.
Northwest Biotherapeutics Inc., of Bothell, Wash., added Scott Stromatt as vice president and chief medical officer.
Orphan Medical Inc., of Minneapolis, added Thomas King to its board and named David Fuller vice president of medical affairs.
OSI Pharmaceuticals Inc., of Melville, N.Y., added Gary Clark as senior director of biostatistics and data management.
Oxford GlycoSciences plc, of Oxford, UK, appointed Don DeGolyer to its board as president of global therapeutics.
Senesco Technologies Inc., of New Brunswick, N.J., added Russell Jones to its scientific advisory board.
Senetek plc, of Napa, Calif., added Franklin Pass and Wade Nichols to its board.
Synaptic Pharmaceutical Corp., of Paramus, N.J., added Robert Zerbe to its board.
Targacept Inc., of Winston-Salem, N.C., added Alan Musso as vice president and chief financial officer.
The Automation Partnership, of Cambridge, UK, added Ron Long as deputy chairman.
The Bay Area Bioscience Center, of San Francisco, selected Brian Cunningham, the president and chief operating officer of Rigel Pharmaceuticals Inc., as the organization’s chairman.
TherImmune Research Corp., of Gaithersburg, Md., added Robert Buckheit as director of infectious disease and immunology.
Third Wave Technologies Inc., of Madison, Wis., appointed Ivan Trifunovich senior vice president and general manager of its genomics business unit.
Tularik Inc., of South San Francisco, promoted Chris Smith to vice president, human resources.
Vasogen Inc., of Toronto, appointed Surya Mohapatra to its board.
Vical Inc., of San Diego, appointed Robert Merton to its board.